NO
Novartis India Limited
NOVARTIND.NS · NSE
₹2,366.00 -2.56% (-₹62.20)
1M +54.45%
Market Cap ₹59.8B
P/E Ratio 61.13x
Div. Yield -
ROE 12.28%
Bulios Fair Price
₹1,374
41.9% downside
Trenutna cena
₹2,366
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica NOVARTIND.NS trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Weak
3/9Valuation
5 /100
Expensive P/E 61.13x
EV/EBITDA 49.84x
P/S 16.13x
Growth
43 /100
Stable Rev. growth 3.78%
FCF growth 25.01%
Book val. growth 4.31%
Profitability
67 /100
Strong Gross margin 38.04%
Net margin 26.38%
Op. margin 26.97%
Quality
56 /100
Average ROE 12.28%
ROIC N/A
ROA N/A
Debt
100 /100
Low Debt/Equity 0.00x
Int. coverage 96.79x
Net debt/EBITDA 0.00x
Stability
45 /100
Moderate Beta 0.32x
Rev. volatility 9.06%
EPS volatility 1,658.10%
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o NOVARTIND.NS
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Vasant Narasimhan
Employees
62
Headquarters
Mumbai